Literature DB >> 3292704

Antibodies to cholinergic neurons in Alzheimer's disease.

J Chapman1, O Bachar, A D Korczyn, E Wertman, D M Michaelson.   

Abstract

Alzheimer's disease (AD) is associated with degenerative changes in nuclei of the basal forebrain which provide most of the cholinergic input to the cortex and hippocampus and with a reduction in presynaptic cholinergic parameters in these areas. Although the etiology and pathogenesis of AD are not known, several reports indicate the involvement of immunological mechanisms. In the present work we examined the existence of antibodies in sera of AD patients that bind specifically to cholinergic neurons. As antigens we employed the purely cholinergic electromotor neurons of the electric fish Torpedo which are chemically homogeneous and cross-react antigenically with human and other mammalian cholinergic neurons. Our findings show that immunoglobulins from sera of AD patients bind to a specific antigen (molecular mass 200 kilodaltons) in the cell bodies and axons of Torpedo electromotor neurons and that the levels of such antibodies are significantly higher in AD patients than in controls. The possible role of these antibodies in the cholinergic dysfunction in AD and their diagnostic potential are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292704     DOI: 10.1111/j.1471-4159.1988.tb01063.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

2.  Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid.

Authors:  D A Loeffler; P L Juneau; H U Nguyen; D Najman; N Pomara; P A LeWitt
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

3.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 4.  New immunological approaches in treating and diagnosing CNS diseases.

Authors:  Kathy Guo; Damir Janigro
Journal:  Pharm Pat Anal       Date:  2013-05

Review 5.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

6.  Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.

Authors:  L Soussan; K Tchernakov; O Bachar-Lavi; T Yuvan; E Wertman; D M Michaelson
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

7.  The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.

Authors:  Toshio Ariga; Chandramohan Wakade; Robert K Yu
Journal:  Int J Alzheimers Dis       Date:  2011-01-09

8.  Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Authors:  Toshio Ariga; Masaru Kubota; Makoto Nakane; Kenji Oguro; Robert K Yu; Susumu Ando
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

Review 9.  Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.

Authors:  Mirela Sarbu; Raluca Ica; Alina D Zamfir
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.